Zheng Quan Shi Bao Wang·2025-01-20 08:44Group 1 - Fosun Pharma's subsidiary, Hunan Dongting Pharmaceutical Co., Ltd., received approval from the National Medical Products Administration for the marketing registration of Oxazepam tablets, which are primarily used for short-term relief of anxiety, tension, and agitation, as well as for insomnia and as an adjunct treatment for anxiety with depression, and to alleviate acute alcohol withdrawal symptoms [1] - The same day, another subsidiary, Jinzhou Aohong Pharmaceutical Co., Ltd., also received approval for the marketing registration of Methoxamine hydrochloride injection, which is used for (1) preventing and treating acute hypotension during epidural anesthesia; (2) treating hypotension due to bleeding, drug allergies, surgical complications, and shock from brain injury or brain tumors; (3) supportive treatment for hypotension caused by cardiogenic shock or sepsis [1]